Preview

Obstetrics, Gynecology and Reproduction

Advanced search

Reproductive function preservation in women with cervical cancer: treatment strategy

https://doi.org/10.17749/2313-7347/ob.gyn.rep.2026.696

Abstract

Introduction. Cervical cancer (CC) is a leading cause of reproductive function loss and the most common oncological pathology of the female reproductive system. Modern treatment methods (surgical, radiation, chemotherapeutic) increase survival but often result in infertility. Therefore, the development of organ-preserving approaches that allow fertility preservation is relevant.

Aim: to analyze available publications assessing preservation of reproductive function after СС treatment, effectiveness of methods, and identify key success factors.

Materials and Methods. A systematic review was conducted in accordance with the PRISMA 2020 guidelines. The search for publications from 2000 to 2025 was performed in PubMed/MEDLINE, Cochrane Library, eLibrary.ru, and CyberLeninka databases. The selection process identified 45 publications that met the inclusion criteria: original research, systematic reviews, meta-analyses, and clinical cases describing fertility-sparing strategies providing data on oncological and reproductive outcomes.

Results. Modern organ-preserving methods, including various types of trachelectomy, conization, neoadjuvant chemotherapy, and assisted reproductive technologies, allow achieving oncological safety while preserving reproductive potential in selected patients with early-stage СС.

Conclusion. Modern organ-preserving approaches in СС treatment hold a promise in oncogynecology, enabling the combination of treatment radicality with the maintenance of reproductive capabilities.

About the Authors

L. L. Dzhikiia
Sechenov University
Russian Federation

Luiza L. Dzhikiia

8 bldg. 2, Trubetskaya Str., Moscow 119048



S. A. Mistyukova
Patrice Lumumba Peoples' Friendship University of Russia
Russian Federation

Sofia A. Mistyukova

6 Miklukho-Maklaya Str., Moscow 117198



A. N. Karpushov
Archbishop Luke Tambov City Clinical Hospital
Russian Federation

Alexey N. Karpushov, MD

6 Gogol Str., Tambov 392023



N. M. Muratov
Sechenov University
Russian Federation

Nikita M. Muratov

8 bldg. 2, Trubetskaya Str., Moscow 119048



Z. Z. Khalifaeva
Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Russian Federation

Zarema Z. Khalifaeva, MD

1 Ostrovityanova Str., Moscow, 117513



D. M. Omarova
Stavropol State Medical University, Ministry of Health of the Russian Federation
Russian Federation

Dana M. Omarova

310 Mira Str., Stavropol 355017 



I. B. Ersinoeva
Stavropol State Medical University, Ministry of Health of the Russian Federation
Russian Federation

Iman B. Ersinoeva

310 Mira Str., Stavropol 355017 



N. A. Guseynov
Patrice Lumumba Peoples' Friendship University of Russia
Russian Federation

Nidjat A. Guseynov, MD, PhD

6 Miklukho-Maklaya Str., Moscow 117198



References

1. Sung H., Ferlay J., Siegel R. L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

2. Kaprin A.D., Starinskii V.V., Shakhzadova A.O. The state of oncological care for the population of Russia in 2022. [Sostoyanie oncologicheskoj pomoshchi naseleniyu Rossii v 2022 godu]. M.: MNIOI im. P.A. Gertsena — filial FGBU NMITs radiologii Minzdrava Rossii, 2023. 239 p. (In Russ.).

3. Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021;155 Suppl 1(Suppl 1):28– 44. https://doi.org/10.1002/ijgo.13865.

4. Rajaram S., Gupta B. Screening for cervical cancer: сhoices & dilemmas. Indian J Med Res. 2021;154(2):210–20. https://doi.org/10.4103/ijmr.IJMR_857_20.

5. Li J. Improving pregnancy outcomes in fertility preserved cervical cancer patients: big challenge after radical trachelectomy. J Gynecol Oncol. 2019;30(3):e73. https://doi.org/10.3802/jgo.2019.30.e73.

6. Poddar P., Maheshwari A. Surgery for cervical cancer: consensus & controversies. Indian J Med Res. 2021;154(2):284–92. https://doi.org/10.4103/ijmr.IJMR_4240_20.

7. Dicu-Andreescu I.G., Marincaș A.-M., Ungureanu V.-G. et al. Current therapeutic approaches in cervical cancer based on the stage of the disease: is there room for improvement? Medicina (Kaunas). 2023;59(7):1229. https://doi.org/10.3390/medicina59071229.

8. Cintra G.F., Derchain S.F.M., Bicalho D.S. et al. Cervical cancer in pregnancy. Rev Bras Ginecol Obstet. 2023;45(5):293–6. https://doi.org/10.1055/s-0043-1770142.

9. LeJeune C., Mora-Soto N., Storgaard L. et al. Cervical cancer in pregnancy. Semin Perinatol. 2025;49(2):152038. https://doi.org/10.1016/j.semperi.2025.152038.

10. Hammer A., Haubjerg L., Gibrael H.S. et al. Screening, diagnostics, and treatment of cervical cancer in pregnancy. Ugeskr Laeger. 2022;184(35):V03220187. (In Danish).

11. Bebneva T.N., Dikke G.B. Low-grade intraepithelial cervical lesions in pregnant women with HPV and vaginal biocenotic disorders. [Intraepitelial'nye porazheniya shejki matki nizkoj stepeni riska u beremennyh zhenshchin s VPCh i narusheniyami biocenoza vlagalishcha]. Akusherstvo i ginekologiya. 2018;(11):152–8. (In Russ.). https://doi.org/10.18565/aig.2018.11.152-158.

12. Ermolova N.V., Petrov Yu.A., Kuznetsova A.I. Pregnancy and cervical cancer. [Beremennost' i rak shejki matki]. Glavnyj vrach Yuga Rossii. 2022;(2):83. (In Russ.).

13. Kornovski Y., Ivanova Y., Kostov S. et al. Gynaecological oncologic diseases and pregnancy. Wiad Lek. 2021;74(8):1984–7.

14. Lee C.-Y., Chen Y.-L., Chiang Y.-C. et al. Outcome and subsequent pregnancy after fertility-sparing surgery of early-stage cervical cancers. Int J Environ Res Public Health. 2020;17(19):7103. https://doi.org/10.3390/ijerph17197103.

15. Feichtinger M., Rodriguez-Wallberg K.A. Fertility preservation in women with cervical, endometrial or ovarian cancers. Gynecol Oncol Res Pract. 2016;3:8. https://doi.org/10.1186/s40661-016-0029-2.

16. Perrone A.M., Bovicelli A., D'Andrilli G. et al. Cervical cancer in pregnancy: analysis of the literature and innovative approaches. J Cell Physiol. 2019;234(9):14975–90. https://doi.org/10.1002/jcp.28340.

17. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Cervical Cancer. 2025. Available at: https://www.nccn.org/search-result?indexCatalogue=nccnsearch-index&searchQuery=Cervical%20Cancer. [Accessed: 15.09.2025].

18. Reneé Franklin C., Tanner E.J. 3rd. Where are we going with sentinel lymph node mapping in gynecologic cancers? Curr Oncol Rep. 2018;20(12):96. https://doi.org/10.1007/s11912-018-0744-4.

19. Clinical guidelines "Cervical cancer". [Klinicheskie rekomendacii «Rak shejki matki»]. Moscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2024. 84 p. (In Russ.). Available at: https://glavonco.ru/upload/iblock/273/273ec04ae83eef64128844f066d8a6be.pdf?ysclid=mm10hkv9tc321150521. [Accessed: 15.09.2025].

20. Halaska M.J., Drochytek V., Shmakov R.G., Amant F. Fertility sparing treatment in cervical cancer management in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2021;75:101–12. https://doi.org/10.1016/j.bpobgyn.2021.03.014.

21. Levy L., Meuwly J.Y., Sarivalasis A. et al. Survival of the fetus: cervical cancer and pregnancy, a challenging combination. Lancet. 2020;396(10252):725. https://doi.org/10.1016/S0140-6736(20)31794-3.

22. Nguyen T., Nougaret S., Castillo P. et al. Cervical cancer in the pregnant population. Abdom Radiol (NY). 2023;48(5):1679–93. https://doi.org/10.1007/s00261-023-03836-x.

23. Rosyuk E.A., Oboskalova T.A., Zornikov D.L. et al. Clinical and medical history characteristics of pregnant women with different cervical cytology results. [Kliniko-anamnesticheskaya harakteristika beremennyh zhenshchin s razlichnymi zaklyucheniyami citologicheskogo issledovaniya shejki matki]. Akusherstvo i ginekologiya. 2025;(1):73–81. (In Russ.). https://doi.org/10.18565/aig.2024.226.

24. Ramirez P.T., Frumovitz M., Pareja R. et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895–904. https://doi.org/10.1056/NEJMoa1806395.

25. Salman L., Covens A. Fertility preservation in cervical cancer-treatment strategies and indications. Curr Oncol. 2024;31(1):296–306. https://doi.org/10.3390/curroncol31010019.

26. Mosseri J., Hocquemiller R., Mergui J.-L. et al. Laser conization for cervical intraepithelial neoplasia: effectiveness and obstetric outcomes. J Gynecol Obstet Hum Reprod. 2022;51(4):102341. https://doi.org/10.1016/j.jogoh.2022.102341.

27. Schmeler K.M., Pareja R., Lopez Blanco A. et al. ConCerv: а prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021;31(10):1317–25. https://doi.org/10.1136/ijgc-2021-002921.

28. Williams N.L., Werner T.L., Jarboe E.A., Gaffney D.K. Adenocarcinoma of the cervix: should we treat it differently? Curr Oncol Rep. 2015;17(4):17. https://doi.org/10.1007/s11912-015-0440-6.

29. Musunuru H.B., Pifer P.M., Mohindra P. et al. Advances in management of locally advanced cervical cancer. Indian J Med Res. 2021;154(2):248–61. https://doi.org/10.4103/ijmr.IJMR_1047_20.

30. Horne Z.D., Karukonda P., Kalash R. et al. Single-institution experience in 3D MRI-based brachytherapy for cervical cancer for 239 women: can dose overcome poor response? Int J Radiat Oncol Biol Phys. 2019;104(1):157- 164. https://doi.org/10.1016/j.ijrobp.2018.12.042.

31. Korneva O.V., Trishkin A.G., Chernyshova A.L., Vyalova K.V. A clinical case of preservation of reproductive potential in a patient with invasive cervical cancer. [Klinicheskij sluchaj sohraneniya reproduktivnogo potenciala u pacientki s invazivnym rakom shejki matki]. Opuholi zhenskoj reproduktivnoj sistemy. 2023;19(2):138–42. (In Russ.). https://doi.org/10.17650/1994-4098-2023-19-2-138-142.

32. Máté S. Medical therapy of cervical cancer. Magy Onkol. 2022;66(4):315– 23. (In Hungarian).

33. Mamontova A.S., Smirnova O.A., Nyuganen A.O. et al. Results of dosedense neoadjuvant chemotherapy w in the treatment of stages IB2-IIB cervical cancer. [Rezul'taty primeneniya intensifitsirovannoy neoad"yuvantnoy khimioterapii v lechenii raka sheyki matki IB2-IIB stadii]. Opuholi zhenskoj reproduktivnoj sistemy. 2022;18(4):85–97. (In Russ.). https://doi.org/10.17650/1994-4098-2022-18-4-85-97.

34. Rerberg A.G., Kostin A.A., Boyko A.V. et al. Neoadjuvant combination chemotherapy in a patient with cervical cancer IIIB stage with the use of intra-arterial administration of platinum drugs. [Neoad"yuvantnaya kombinirovannaya khimioterapiya u bol'noy rakom sheyki matki IIIB stadii s ispol'zovaniem vnutriarterial'nogo vvedeniya preparatov platiny]. Issledovaniya i praktika v meditsine. 2017;4(2):61–7. (In Russ.). https://doi.org/10.17709/2409-2231-2017-4-2-8.

35. Ovodenko D.L., Khabas G.N., Aleshikova O.I. et al. Neo-adjuvant chemotherapy and laparoscopic radical hysterectomy for locally advanced cervical cancer. [Neoad"yuvantnaya khimioterapiya i laparoskopicheskaya radikal'naya gisterektomiya pri mestnorasprostranennom rake sheyki matki]. Akusherstvo i ginekologiya. 2017;(4):101–7. (In Russ.). https://doi.org/10.18565/aig.2017.4.101-7.

36. Zusterzeel P.L.M., Aarts J.W.M., Pol F.J.M. et al. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy as fertilitypreserving treatment for patients with FIGO 2018 stage 1B2 cervical cancer. Oncologist. 2020;25(7):e1051–9. https://doi.org/10.1634/theoncologist.2020-0063.

37. Zagouri F., Korakiti A.M., Zakopoulou R. et al. Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis. Cancer Treat Rev. 2019;79:101885. https://doi.org/10.1016/j.ctrv.2019.08.001.

38. Mandic A., Maricic S., Malenkovic G. et al. Neoadjuvant chemotherapy in locally advanced cervical cancer in pregnancy – review of the literature. J BUON. 2020;25(2):597–604.

39. Ulrikh E.A., Borshchevskiy V.G., Zakharov I.S. et al. Chemotherapy for cervical cancer and contraception: discussion issues and clinical case. [Himioterapiya raka shejki matki i kontracepciya: diskussionnye voprosy i klinicheskij sluchaj]. Opuholi zhenskoj reproduktivnoj sistemy. 2024;20(1):147–52. (In Russ.). https://doi.org/10.17650/1994-4098-2024-20-1-147-152.

40. van Kol K.G.G., Vergeldt T.F.M., Bekkers R.L.M. Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates. Gynecol Oncol. 2019;155(3):515– 21. https://doi.org/10.1016/j.ygyno.2019.09.025.

41. Zaccarini F., Sanson C., Maulard A. et al. Cervical cancer and fertilitysparing treatment. J Clin Med. 2021;10(21):4825. https://doi.org/10.3390/jcm10214825.

42. Vartanyan E.V., Dobrohotova Yu.E., Devyatova E.A., Tsaturova K.A. Females’ fertility preservation in malignancies. [Sokhraneniye zhenskoy fertil'nosti pri onkologicheskikh zabolevaniyakh]. Problemy reproduktsii. 2020;26(4):68–76. (In Russ.). https://doi.org/10.17116/repro20202604168.

43. Bunyaeva E.S., Kirillova A.O., Khabas G.N. et al. Modern methods of preserving fertility in patients with cancer of the reproductive system. [Sovremennye metody sokhraneniya fertil'nosti u patsiyentok s onkologicheskimi zabolevaniyami organov reproduktivnoy sistemy]. Akusherstvo i ginekologiya. 2021;(7):45–52. (In Russ.). https://doi.org/10.18565/aig.2021.7.45-52.

44. Gamzatova Z.H., Komlichenko E.V., Kostareva A.A. et al. First experience in the cryopreservation of ovarian tissue. [Pervyy opyt kriokonservatsii ovarial'noy tkani]. Issledovaniya i praktika v meditsine. 2015;2(1):51. (In Russ.).

45. Nazarenko T.A., Burduli A.G., Martirosyan Ya.O., Dzhanashvili L.G. Cryopreservation of reproductive material in cancer patients. [Kriokonservatsiya reproduktivnogo materiala u onkologicheskikh bol'nykh]. Akusherstvo i ginekologiya. 2019;(9):40–9. (In Russ.). https://doi.org/10.18565/aig.2019.9.40-49.


What is already known about this subject?

► Cervical cancer (СС) frequently affects women of reproductive age, necessitating development of fertility-preserving approaches.

► Radical trachelectomy is the standard for fertility preservation in early-stage СС in selected patients.

► Fertility-sparing surgeries show oncological outcomes comparable to radical treatment while preserving fertility.

What are the new findings?

► Modern fertility preservation strategies at various СС stages are systematized, including pre-surgery neoadjuvant chemotherapy for tumor size reduction.

► The effectiveness of less radical interventions (simple trachelectomy, conization) with a high pregnancy rate has been analyzed.

► Key success factors are identified as follows: tumor size ≤ 2 cm, no lymphovascular space invasion, and careful patient selection.

How might it impact on clinical practice in the foreseeable future?

► Expanded indications for fertility-sparing СС treatment through neoadjuvant chemotherapy.

► Implementing personalized approach to selection method based on tumor characteristics and reproductive plans.

► Development of multidisciplinary collaboration between gynecologic oncologists and reproductive specialists to improve outcomes.

Review

For citations:


Dzhikiia L.L., Mistyukova S.A., Karpushov A.N., Muratov N.M., Khalifaeva Z.Z., Omarova D.M., Ersinoeva I.B., Guseynov N.A. Reproductive function preservation in women with cervical cancer: treatment strategy. Obstetrics, Gynecology and Reproduction. 2026;20(2):352-362. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2026.696

Views: 410

JATS XML

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)